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1. Introduction
Aortic aneurysm involves the aorta which is one of the large arteries through which blood
passes from the heart to the rest of the body. Aortic aneurysm is a relatively common find‐
ing in the elderly patients because of aging, hypertension, or atherosclerosis, but it is rarely
seen in childhood. In the adult population, the incidence of aortic aneurysm has been esti‐
mated to be 5.9 cases per 100000 person-years. However, there are no real data about the
incidence of aortic aneurysm in childhood [1]. Aortic aneurysm is mostly seen in the ascend‐
ing aorta, but it may also be seen in the descending aorta and /or aortic branches [2, 3]. Al‐
though it is rare, aortic aneurysm can be important cause of mortality in children and
adolescents. Aortic aneurysm may be related to hereditary diseases (Marfan syndrome,
Loeys –Dietz syndrome, Ehler-Danlos syndrome, Arterial Tortuosity Syndrome, Cutis laxa
syndrome, Alagille syndrome, and Noonan Syndrome), or non genetic diseases (bicuspid
aortic valve, coarctation of aorta, tetralogy of Fallot, and aortitis syndromes). In this review,
causes, clinical findings, diagnostic methods, and treatment modalities of aortic aneurysm in
children and adolescents have been discussed.
2. Genetic causes of aortic aneurysm
2.1. Marfan syndrome
Marfan syndrome, characterized by otosomal dominant inheritance, I was first described in
1986. The syndrome is due to more than 500 mutations in the fibrillin 1 gene on chromo‐
some 15q21. Expression of the disease is variable and 30% of cases represent new mutation.
Although cardiovascular manifestations are variable, the incidence (35-80%) of aortic root
dilatation, mitral regurgitation in Marfan patients depends on the patient’s age. In Marfan
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syndrome, fibrillin-1 gene mutation leads to elastic fiber fragmentation and cystic medial ne‐
crosis. Fibrillin-1 is a matrix glycoprotein and a constituent of fibrils. Apart from structural
abnormalities, a defective subenthelial fibrillin leads to decreased distensibility, and in‐
creased aortic stiffness was showed in patients with Marfan syndrome. Excessive transform‐
ing growth factor β(TGFβ) activity, defect in gene encoding TGF β receptor and complex
interaction between the fibrillin, microfibrils, TGFβ and its receptor have been proposed hy‐
pothesis of defective arterial wall matrix. Aortic dilatation may be related to arterial muscle
cell apoptosis due to angiotensin-II receptor signalling pathways. Aortic stiffness has been
showed to be an independent predictor for progressive aortic dilatation and dissection [4].
Beta blocker and ACE inhibitor therapy have been showed to decrease aortic stiffness and
delay aortic surgery [5].
Clinical findings of Marfan syndrome are variable. Although most of the patients are diag‐
nosed after 10 years, physical findings may be present at birth. The height of the patient in‐
creases. An arm span exceeds the height. Marfan patients have hypermobile joints, chest
deformities, long and thin fingers, kyphoscoliosis, high palates, inguinal hernias, and dental
abnormalities. Figure 1 shows long and thin fingers; figure 2 shows increased arm length
and height in a Marfan syndrome patient. Ocular abnormalities such as lens subluxation,
and/or myopia may be present in nearly 75% of the patients. Cardiovascular manifestation
including aortic aneurysm, mitral valvar prolapse less severe in children than adults. Ghent
nosology has been developed for diagnosis of Marfan syndrome in 1996. The 1996 Ghent cri‐
teria were adopted worldwide, but diagnostic criteria were revised in 2010, highlighting
aortic root aneurysm and lens subluxation more [6, 7].
Figure 1. shows long and thin fingers in a 13-years-old patient with Marfan syndrome
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Figure 2. shows increased height and arm length in a 13-year-old patient with Marfan syndrome
According to Ghent’s criteria, positive family history of Marfan syndrome (known fibrillin 1
mutation in the parent(s) or siblings), cardiac findings including aortic root dilatation, aortic
dissection, and lumbosacral dural ectasia are the major criteria. Mitral valvar prolapse, cal‐
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cific mitral annulus (age< 40 years), other aortic dilatations or dissections (age <50 years),
spontaneous pneumothorax, apical blebs, skin abnormalities including recurrent or incision‐
al hernias, and stria atrophicae are considered minor criteria. Recently, diagnostic criteria
were revised nosology established for adult Marfan population [8, 9, 10].
Cardiovascular manifestations, especially aortic aneurysm and dissection, are the most com‐
mon causes of mortality. Aortic aneurysms are usually located in the ascending aorta but it
may also be located in the abdominal aorta or aortic branches [11, 12, 13]. Figure 3 and 4
show an aneurysm in the right renal artery and multiple aneurysm in the hepatic artery in a
16-year-old Marfan patient. Figure 5 shows intraoperative appearance of an aneurysm in the
ascending aorta in an 18-year-old patient with Marfan syndrome.
Figure 3. shows a large aneurysm in the right renal artery of a 16-year-old patient with Marfan syndrome
Elective root replacement should be seriously considered in any Marfan patient with signifi‐
cant root dilatation. Reoperation is required for half of Marfan syndrome patients [14]. Risk
of sudden death or aortic dissection remains low in patients with Marfan syndrome and
aortic diameter between 45-49 mm. Aortic diameter of 50 mm appears to be reasonable
threshold for prophylactic surgery [15, 16].
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The findings extend the mutation spectrum of Marfan syndrome, and that mutations at the
F-helix in the kinase domain of TGFBR2 may be associated with the development of severe
Figure 4. shows multiple aneurysms in the hepatic artery of a 16- year- old patient with Marfan syndrome
Figure 5. shows intraoperative appearance of the ascending aorta aneurysm in an 18- year-old patient with Marfan
Syndrome ( By courtesy of Prof Dr Nevzat Erdil)
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cardiovascular and skeletal lesions and minor ocular disorders [17, 18]. For patients with
Marfan syndrome, failed aortic surveillance and consequent emergency dissection repair
have important long-term implications with regard to the status of distal aorta; they need
multiple procedures for better quality of life. These findings emphasize the importance of
aortic surveillance and timely elective aortic root aneurysm repair for patients with Marfan
syndrome [19, 20]. Prophylactic propranolol treatment delays progression of aortic root dila‐
tation. Because the patogenetic role of angiotensin II receptor signaling pathway and TGFβ
in Marfan syndrome is clearly understood, angiotensin converting enzyme inhibitors should
be started in patients with Marfan syndrome. Timing of surgery including aortic root sur‐
gery and/or valve replacement must be determined according to the risk and benefit of the
surgery. Because annual mortality rate is 5% in patients with an aortic root greater than 50
cm, elective surgery must be performed before aortic root reaches 55 mm. For patients with
a family history of aortic dissection and likelihood of pregnancy, elective surgery should be
performed while the aortic root is in a smaller size. Upon diagnosis of Marfan syndrome,
echocardiographic evaluation should be done, and beta blocker treatment and angiotensin
converting enzyme inhibitors should be started after aortic root measurement. Patients with
this syndrome should be followed up with echocardiograph periodically, and if it is necessa‐
ry, with magnetic resonance imaging. Patients with Marfan syndrome who remain undiag‐
nosed until adulthood are more likely to require surgical intervention. Early diagnosis of
Marfan syndrome can improve the long-term outcome [21].
Infantile  form of  Marfan syndrome is  a  rare  condition in which the ocular  and skeletal
abnormalities are similar to those in the adult form. Myxomatous changes of mitral and
tricuspid valves and chordaes with elongation of  chordae tendineas are seen commonly
in infantile form. Pulmonary emphysematous changes are also seen. Cardiovascular mor‐
bidity  is  commonly  related  to  mitral  and  tricuspid  valve  disease  rather  than  aortic
aneurysm and dissection.  Family history is  rare and death commonly occurs  in 2  years
after diagnosis [22, 23].
2.2. Loeys-Dietz syndrome
Loeys-Dietz syndrome, which was first described in 2005, resembles Marfan syndrome,
which is also inherited otosomal dominant, aortic aneurysm, and vascular pathology in
Loeys-Dietz syndrome is more probable than in Marfan patients. It is caused by heterozy‐
gous mutations in the genes encoding type I and II transforming growth factor-β (TGFBR1,
TGFBR2) and is characterized by hyperteleroism, bifid uvula, cleft palate, arterial tortuosity,
aneurisms of the ascending aorta, and dissection. Despite phenotypical resemblance, Loeys-
Dietz syndrome can be differentiated from Marfan syndrome by palatal involvement and
hyperteleroism. Aneurysms may occur in young ages and lead to aortic dissection in Loeys-
Dietz Syndrome. Elective surgery is recommended at an aortic root diameter of 40 mm. In
Loeys-Dietz syndrome, defective microfibrils due to excessive activity of Transforming
Growth Factor β activity lead to defective formation of matrix in the arterial wall and thus,
aortic aneurysms [24, 25, 26].
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Valve sparing operation of the aortic root is ideal in treating young patients with aortic root
aneurysm with normal or minimally diseased aortic cusps to avoid the disadvantages of
prosthetic valve replacements [27, 28].
Loeys-Dietz syndrome is an aggressive aortic aneurysm syndrome that can be addressed by
prophylactic aortic root replacement with low operative risk. Valve-sparing procedures
have encouraging early and midterm results, similar to Marfan syndrome, and are an attrac‐
tive option for young patients [29, 30, 31].
2.3. Ehler-Danlos syndrome
The other genetic cause of aortic aneurysm is Ehler-Danlos syndrome. Ehler-Danlos syn‐
drome is a genetically heterogeneous disorder of collagen and extracellular matrix and it is
characterized by abnormal collagens. Although more than 10 subtypes have been described,
90% of patients with Ehler –Danlos Syndrome encompass six subtypes. Hyper extensibility
of joints and skin, distinctive facial appearance, easy bruising, poor healing of wounds,
smooth and rubbery palm and soles, blue sclera, epicanthal folds, lens subluxation, poor
muscle tone are clinical findings of Ehler-Danlos. Premature death can occur in the most se‐
vere forms due to poor muscle tones. Cardiovascular findings are seen in subtype IV. In Eh‐
ler Danlos type IV collagen type III α-1 gene mutation leads to abnormal type III collagen in
the vascular wall, skin and other organs. These patients carry aortic dissection risk and it
does commonly occur after the 3rd decade. Aortic aneurysm can be seen in Ehler-Danlos
type IV patients, but dissection is a rare condition in these patients [32, 33, 34, 35].
2.4. Arterial tortuosity syndrome
Arterial tortuosity syndrome is an autosomal recessive disorder characterized by tortuosity of
the aorta and its major branches due to SLC2A 10 genes that encodes for the glucose trans‐
porter GLUT10. Coucke et al reported location of the arterial tortuosity syndrome locus to
20q13 to a 1.2 Mb region containing 7 genes. Aortic aneurysms can also be seen in Arterial
tortuosity syndrome patients [36, 37, 38].
2.5. Turner syndrome
Turner syndrome is an aneuploidy syndrome [45, XO) characterized by short stature, webbed
neck, and infertility. Bicuspid aortic valve, coarctation of the aorta, aortic dilatation, pseudo‐
coarctation, aortic aneurysm, and dissection are common in Turner patients. Histological
evidence of cystic medial necrosis has been reported in Turner syndrome. The prevalence of
aortic dilation and aneurysm is lower in the young girls and women with Turner syndrome
than in older Turner syndrome population [39, 40].
2.6. Noonan syndrome
Noonan syndrome is characterized by hypertelorism, a downward eyeslant, and low-set pos‐
terior rotated ears, short stature, short neck with webbing, cardiac anomalies, epicanthic
folds, deafness, motor delay, and bleeding diathesis. Noonan syndrome is similar to Turner
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syndrome but a genetically heterogeneous disease (PTPN11, RAS-MAPK mutations) charac‐
terized by dysplastic pulmonary valve, pulmonary stenosis [41,42]. Aortic aneurysm and
dissection are rarely seen in Noonan syndrome [43].
2.7. Alagille syndrome
Alagille syndrome is an autosomal dominant syndrome that has been defined as paucity of
intrahepatic bile ducts, cholestasis, cardiac disease, skeletal abnormalities, ocular abnormali‐
ties and characteristic facial appearance, ocular and renal abnormalities caused by heterozy‐
gous mutation in the Jagged -1 gene on chromosome 20p12. Another form of Alagille
syndrome is caused by mutation in the NOTCH2 gene. Basillary artery aneurysm, middle
cerebral artery aneurysm, aortic coarctation and aortic aneurysms have been reported in
Alagille patients [44, 45, 46].
2.8. Cutis laxa
Cutis laxa is rare genetically heterogeneous disorder characterized by loose, sagging disease
from early age. Autosomal dominant and recessive forms of cutis laxa have been described.
In patients with cutis laxa, skin is loose and appears to be larger for the body [47]. Cutis laxa
phenotypically resembles Ehler –Danlos syndrome due to hypermobile joints, fragility of
skin, and easy bruising. However, the skin slowly recoils after it is stretched. Inguinal her‐
nias and rectal prolapses may be seen [48]. Pulmonary stenosis, pulmonary emphysema, cor
pulmonale, mitral regurgitation, dysplastic valvar disease and aortic aneurysm have also
been reported in cutis laxa syndrome.
Fibulin-4 is a member of the fibulin family, a group of extracellular matrix proteins predom‐
inantly expressed in medial layers of large veins and arteries. Fibulin-4 deficiency has been
showed in autosomal recessive cutis laxa patients [49].
2.9. Aneurysms-osteoarthritis syndrome
Aneurysms-osteoarthritis syndrome (AOS) is a new autosomal dominant syndromic form of
thoracic aortic aneurysms and dissections caused by mutations SMAD3 gene, characterized
by the presence of arterial aneurysms and tortuosity, mild skeletal, craniofacial and cutane‐
ous anomalies, and early onset osteoarthritis [50]. Smooth muscle alpha-actin (ACTA2] mu‐
tations have been determined to be associated with aortic aneurysm and dissection in some
families [51].
3. Non-genetic causes of aortic aneurysm
Non genetic causes of aortic aneurysm are bicuspid aorta, coarctation of aorta, aortitis syn‐
dromes, systemic hypertension, and vasculitis.
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3.1. Bicuspid aortic valve
Congenitally bicuspid aortic valve is the most common congenital anomaly, with a preva‐
lence of 0.5 to 2 in 100 individuals. A bicuspid aortic valve with a fused commisure and an
eccentric orifice accounts for the most common form of aortic stenosis. Bicuspid aortic valve
patients have also variable degrees of aortic insufficiency and aortic aneurysm in addition to
aortic stenosis (figure 6). Cystic medial necrosis has been reported in the aortic wall. There‐
by, aortic aneurysm may lead to aortic dissection [52, 53]. Hope et al determined that four-
dimensional flow MR imaging showed helical systolic flow in the ascending aorta of
patients with bicuspid aortic, including those without aneurysm or aortic stenosis. They
stated that identification and characterization of eccentric flow jets in these patients may
help identify those at risk for development of ascending aortic aneurysm [54].
Figure 6. shows aneurysm of the ascending aorta secondary to bicuspid aortic valve and pseudocoarctation in a 13-
year-old patient.
3.2. Coarctation of aorta
Coarctation of aorta occurs in 8% to 10% of all congenital heart defects. As many as 85% of
patients with aortic coarctation patients have a bicuspid aortic valve. Aortic aneurysm can
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be seen in untreated coarctation of aorta patients, after balloon dilatation and after surgical
treatment or infective endocarditis. Aneurysm formation at the site of the dilatation with
balloon angioplasty markedly in different series, but in generally rare. In the earlier era of
balloon angioplasty, the incidence of aneurysm was high due to over dilatation with balloon
catheter but recent series showed that aneurysm incidence decreased after balloon angio‐
plasty. The pathology in the aneurysms that were operated was tears through the intima
and media of the aorta. Aneurysm of the aorta is rare but can be seen after surgical repair
especially with patch aortoplasty. When discrete aneurysm was determined after surgical
repair or balloon angioplasty, it should be followed closely with CT, MRI, or angiographic
imaging. A discrete aneurysm can be treated by using a covered stent [55]. Aortic aneur‐
ysms are less reported but may be rarely seen after bare stent implantation [56]. Aortic
aneurysm formation complicating aortic coarctation carries a risk of rupture with high mor‐
tality. Covered stents are a safe and effective treatment with low risk of complications for
the treatment of coarctation associated with aortic wall aneurysm [57, 58, 59].
Figure 7. shows aortic aneurysm in a 14-year-old patient with operated tetralogy of Fallot.
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3.3. Tetralogy of Fallot
Tetralogy of Fallot occurs in 10 % of all congenital heart defects. Although tetralogy of Fallot
include ventricular septal defect, overriding of aorta, and right ventricular outflow tract ob‐
struction, it can present with a pulmonary atresia, absent pulmonary valve. Tetralogy of Fal‐
lot patients also have variable degrees of aortic dilatation; it sometimes leads to aortic
aneurysm and dissection due to volume overload, abnormalities of tunica media, elastic fi‐
bers and collagen in the aortic wall [60]. Histological abnormalities of aortic wall character‐
ized by medial necrosis, fibrosis, and elastic fragmentation of the aortic root and ascending
aorta lead to subsequent aortic root dilatation and aneurysm in patients with tetralogy of
Fallot [61]. Aortic aneurysm has also been described after aortic arch repair [62].
3.4. Aortitis syndromes
Aortic aneurysm can be seen in aortitis syndromes related to syphilis, inflammatory bowel
disease, and vasculitic syndromes. The primary systemic vasculitis is a group of autoim‐
mune conditions characterized by occlusion, stenosis or aneurysmal dilations secondary to
inflammation [63, 64, 65]. Aortic aneurysm may also be related to infective endocarditis (fig‐
ure 8) or septicemia [66, 67, 68, 69, 70, 71].
Figure 8. shows mycotic aneurysm at the postcoarctation area in a 16-year-old patient with coarctation of the aorta
and infective endocarditis.
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Aortic aneurysm has also been rarely described with Wiskott-Aldrich syndrome but real
cause is not known [72].
3.5. Homosystinuria
Homosystinuria is an autosomal recessive metabolic disorder due to deficiency of cystathio‐
nin synthase which phenothpically resembles Marfan syndrome. Major cardiovascular com‐
plication of homosystinuria is premature atherosclerotic changes in the vascular system.
Vitamin B6 and folic acid treatment helps reduce homocystein levels [73, 74].
4. Clinical presentation and diagnosis
Clinical  presentation of  aortic  aneurysm depends on underlying disease,  size,  and loca‐
tion of aneurysm as well  as presence of aortic dissection.  Patients with aortic aneurysm
related to genetic cause have specific phenotypical appearance such as having hypermo‐
bile joints,  chest  deformities,  long and thin fingers,  kyphoscoliosis,  high palate,  inguinal
hernias, and/or aracnodactilia (Figure 1, 2). If patients have Marfan like appearance, fami‐
ly  history  should be  sought.  Decreased femoral  pulsus,  systolic  ejection murmur in  the
aortic area can be detected during cardiac examination in patients with aortic aneurysm
related to coarctation of the aorta or bicuspid aortic valve. Diastolic murmur can be heard
secondary to aortic insufficiency or apical pansystolic murmur can be heard secondary to
mitral valve insufficiency related to mitral valve prolapse. It is important to evaluate aort‐
ic  dissection if  presence of  sharp chest  and abdominal pain in patients who have aortic
aneurysm.
Transthorasic  and transesophageal  echocardiographic  evaluation is  the  first  step evalua‐
tion  for  the  aortic  aneurysm.  On  transtorasic  echocardiography,  proximal  ascending,
thoracic aorta and proximal abdominal aorta can be visualized by using parasternal long
axis, suprasternal views, and subcostal views. Echocardiographic evaluation can show mi‐
tral  valve proplapse,  aortic  aneurysm, left  ventricular  and/or left  atrial  enlargement sec‐
ondary to the mitral valve or aortic insufficiency, bicuspid aortic valve or coarctation of
the aorta. 2D and colour-coded echocardiographic pictures from the parasternal long axis
and apical four chamber view show mild aortic enlargement at the sinotubular junction,
mitral valve prolapsus and mitral insufficiency in a 13-year-old patient with Marfan syn‐
drome (figures 9, 10, 11, 12). Aortic aneurysm patients are also evaluated by transesopa‐
gheal echocardiography.
The  other  imaging  modalities  are  cardiac  catheterization,  magnetic  resonance  imaging
and computed tomography (figure 3, 4, 6, 7, 8). With the increasing availability of whole
body imaging,  the  role  of  magnetic  resonance  imaging and multidetector  computed to‐
mography  are  increasing  diagnostic  modalities  in  patients  with  aortic  aneurysm/dissec‐
tion [75, 76, 77, 78].
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Figure 9. Long axis echo picture shows mild sinotubular junction in a 13-year-old patient with Marfan syndrome
Figure 10. Long axis echo picture shows mitral valve prolapse in a 13-year-old patient with Marfan syndrome
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Figure 11. Apical four chamber echo picture shows mitral valve prolapse in a 13-year-old patient with Marfan syn‐
drome
Figure 12. Apical four chamber echo picture shows mitral insufficiency secondary to mitral valve prolapse in a 13-
year-old patient with Marfan syndrome
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5. Treatment
Treatment of the cell cultures with dexamethasone induced remarkable up-regulation in the
expression of tropoelastin, fibulin 1 and fibulin 4 encoding mRNAs, leading to normaliza‐
tion of elastic fiber production in fibroblasts with TGFβ-R1 mutations [78].
Among children who have aortic aneurysm, timing of surgical treatment should be weighed
against life expectancy, underlying disease, the size and location of aneurysm and presence
of dissection. It has been showed that beta blocker and ACE inhibitor therapy delay aortic
surgery in patients with aortic aneurysm related Marfan syndrome.
The indications of surgical treatment are aortic size over 5 cm, aneurysm growth rate ex‐
ceeding 1 cm per year, progressive aortic insufficiency, and familial history of early aortic
dissection for most of aortic aneurysm patients. However, since the risk of dissection is
higher in Loeyz-Dietz syndrome, surgery is indicated even at lower diameters of the aorta.
In conclusion, aortic aneurysm is a rare but a lifethreatening condition in childhood. It is
generally related to genetic hereditary syndromes. The patients who have predisposition to
aortic aneurysm should be followed-up closely.
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